| |
| |
|
| Insider
Information: |
Schindel Yair Chaim |
| Relationship: |
10% Owner |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
10,032,209 |
|
|
Indirect Shares
|
3,948,286 |
|
|
| Direct
Value |
$4,473,925 |
|
|
|
Indirect Value
|
$3,539,315 |
|
|
| Total
Shares |
13,980,495 |
|
|
| Total
Value |
$8,013,240 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Adicet Bio, Inc |
ACET |
Director |
2020-09-15 |
0 |
2020-09-15 |
1,104,460 |
Premium* |
|
|
Seer, Inc. |
SEER |
shareholder of 10% hol... |
2021-06-09 |
4,112,235 |
2021-06-09 |
810,961 |
Premium* |
|
|
Viracta Therapeutics Ord Shs |
VIRX |
10% Owner |
2021-02-24 |
5,359,372 |
2021-02-24 |
2,032,865 |
Premium* |
|
|
Ayala Pharmaceuticals, Inc. |
AYLA |
shareholder of 10% hol... |
2023-01-19 |
0 |
2023-01-19 |
0 |
Premium* |
|
|
Advaxis Inc |
ADXS |
10% Owner |
2023-01-19 |
560,602 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADXS |
Advaxis Inc |
10% Owner |
– – • |
2023-01-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
560,602 |
|
- |
|
| AYLA |
Ayala Pharmaceuticals, In... |
shareholder of 10% holder |
– – – |
2023-01-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,991,473) |
0 |
0 |
- |
|
| SEER |
Seer, Inc. |
shareholder of 10% holder |
– – – |
2021-06-09 |
4 |
S |
$30.00 |
$4,941,660 |
I/I |
(164,722) |
810,961 |
0 |
- |
|
| SEER |
Seer, Inc. |
shareholder of 10% holder |
– – – |
2021-06-09 |
4 |
S |
$30.00 |
$25,058,340 |
D/D |
(835,278) |
4,112,235 |
0 |
- |
|
| VIRX |
Viracta Therapeutics Ord ... |
10% Owner |
– – • |
2021-02-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,032,865 |
|
% |
|
| VIRX |
Viracta Therapeutics Ord ... |
10% Owner |
– – • |
2021-02-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,359,372 |
|
% |
|
| SEER |
Seer, Inc. |
10% Owner |
– – • |
2020-12-09 |
4 |
B |
$19.00 |
$1,197,456 |
I/I |
63,024 |
975,683 |
1.5 |
- |
|
| SEER |
Seer, Inc. |
10% Owner |
– – • |
2020-12-09 |
4 |
B |
$19.00 |
$13,802,531 |
D/D |
726,449 |
4,947,513 |
2.45 |
- |
|
| SEER |
Seer, Inc. |
10% Owner |
– – • |
2020-12-08 |
4 |
A |
$0.00 |
$0 |
I/I |
912,659 |
912,659 |
0 |
- |
|
| SEER |
Seer, Inc. |
10% Owner |
– – • |
2020-12-08 |
4 |
B |
$19.00 |
$1,900,000 |
D/D |
100,000 |
4,221,064 |
2.45 |
- |
|
| SEER |
Seer, Inc. |
10% Owner |
– – • |
2020-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,121,064 |
4,121,064 |
0 |
- |
|
| ACET |
Adicet Bio, Inc |
Director |
– • – |
2020-09-15 |
4 |
A |
$0.00 |
$0 |
I/I |
1,104,460 |
1,104,460 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
